VF
OGEN icon

Virtu Financial’s Oragenics OGEN Stock Holding History

Virtu Financial’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,575
Closed -$10K – 2063
2026
Q1 		$10K Buy
+17,575
New +$13.9K ﹤0.01% 1462
2024
Q4 		– Sell
-696
Closed -$8K – 1903
2024
Q3 		$8K Buy
696
+290
+71% +$8.19K ﹤0.01% 1222
2024
Q2 		$13K Sell
406
-350
-46% -$15.8K ﹤0.01% 1099
2024
Q1 		$33K Buy
+756
New +$74.6K ﹤0.01% 1089
2022
Q4 		– Sell
-17
Closed -$7K – 1990
2022
Q3 		$7K Buy
17
+3
+21% +$1.75K ﹤0.01% 1555
2022
Q2 		$9K Sell
14
-8
-36% -$4.62K ﹤0.01% 1430
2022
Q1 		$14K Sell
22
-83
-79% -$60.9K ﹤0.01% 1342
2021
Q4 		$84K Sell
105
-39
-27% -$39.5K 0.01% 1201
2021
Q3 		$165K Buy
144
+108
+300% +$130K 0.01% 973
2021
Q2 		$46K Buy
36
+24
+200% +$31.6K ﹤0.01% 1346
2021
Q1 		$19K Sell
12
-79
-87% -$143K ﹤0.01% 1512
2020
Q4 		$74K Sell
91
-58
-39% -$51K 0.01% 1139
2020
Q3 		$154K Buy
+149
New +$238K 0.03% 644
2019
Q4 		$52K Buy
55
+35
+175% +$31.2K 0.01% 1195
2019
Q3 		$19K Sell
20
-22
-52% -$18.4K ﹤0.01% 1296
2019
Q2 		$37K Buy
42
+35
+500% +$32.1K ﹤0.01% 1283
2019
Q1 		$8K Sell
7
-70
-91% -$110K ﹤0.01% 1347
2018
Q4 		$119K Buy
77
+58
+305% +$114K 0.01% 1093
2018
Q3 		$40K Sell
19
-14
-42% -$16.1K ﹤0.01% 1329
2018
Q2 		$83K Buy
33
+27
+450% +$71K 0.01% 1683
2018
Q1 		$19K Buy
6
+3
+100% +$11.1K ﹤0.01% 1818
2017
Q4 		$13K Buy
3
+2
+200% +$12.6K ﹤0.01% 2252
2017
Q3 		$6K Buy
+1
New +$6.61K ﹤0.01% 2427

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Virtu Financial's OGEN Position: Q2 2026 in Review

Virtu Financial sold out of Oragenics (OGEN) in Q2 2026, closing a stake of 17,575 shares — an estimated $10K sold.

Virtu Financial first reported a position in OGEN in Q3 2017 and held it in 23 quarters. The position peaked at $165K in Q3 2021. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • Virtu Financial reported no remaining Oragenics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 17,575 Oragenics shares in Q2 2026, an estimated $10K.
  • Virtu Financial first reported a position in Oragenics in Q3 2017 and held it in 23 quarters.
  • Virtu Financial's Oragenics position peaked at $165K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.